# Cure Alzheimer's Fund

Cure Alzheimer's Fund is a Foundation based in Wellesley Hills, United States.

## Overview

- **Organization type:** Foundation
- **Headquarters:** Wellesley Hills, United States
- **Region:** North America
- **Address:** Wellesley Hills, MA, United States
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** curealz.org
- **LinkedIn:** https://www.linkedin.com/company/cure-alzheimer%27s-fund

## Regulatory record

- **Reports private funds:** No

## About

A non-profit that funds research with the highest probability of slowing, stopping, or reversing Alzheimer’s disease. | Cure Alzheimer's Fund is a 501c3 non-profit established to provide funding for targeted research with the highest probability of slowing, stopping, or reversing Alzheimer’s disease.

## Sectors

- Healthcare Services

## People

- Timothy Armour — President and CEO
- Rudy Tanzi — Chairman, Research Advisory Board

## Questions

### Who controls research spending at Cure Alzheimer's Fund?

Research allocation is directed by the fund's scientific advisory board, chaired by Rudy Tanzi, professor of neurology at Harvard Medical School and director of the Genetics and Aging Research Unit at MGH. Proposals are peer-reviewed by the board without the indirect-cost overhead typical of government grants.

### Does Cure Alzheimer's Fund invest in for-profit biotech companies?

No. The fund operates exclusively as a grant-making organization. All donor dollars are directed to academic researchers and nonprofit research institutions. The fund does not take equity or participate in commercial ventures.

### What is the fund's relationship to the Tanzi lab?

Rudy Tanzi chairs the fund's Research Advisory Board, but grant decisions are made by a committee of scientists, not by Tanzi alone. The fund requires all board members — including Tanzi — to recuse themselves from votes on proposals they are affiliated with.

### How does the fund differ from the NIH or the Alzheimer's Association?

Cure Alzheimer's Fund targets high-risk, early-stage projects that traditional grant-makers often reject. It operates without the bureaucratic lag of federal agencies, funds at lower overhead, and can move from proposal to grant within weeks rather than months.

### Does the fund have any endowment or investment portfolio?

No publicly disclosed investment portfolio. The fund's model is to grant out essentially all money it raises in the year it is raised. It maintains a small operating reserve but does not function as an asset manager.

## Related profiles

- [Vertice Pharma](https://altss.com/profile/vertice-pharma)
- [Tradesy](https://altss.com/profile/tradesy)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/cure-alzheimers-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology